ENTA
#3091
Enanta Pharmaceuticals, Inc. - Common Stock
12.3 0 USD
-0.02%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
-1.60%
Changement Mensuel
-5.02%
Evolution sur 6 mois
-13.93%
Changement Annuel
+7.80%
Clôture Précédente
12.5 0
Open
12.4 8
Low
12.1 5
High
12.6 4
Financials
- Market Capitalization 358.24 M
- Employee 120
- Founded 1995
- CEO N/A
- Website www.enanta.com
- Headquarter Massachusetts, United States
- FIGI BBG001V9NSB4
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-3.12
ratio cours/chiffre d'affaires
0
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 3058 |  RLMD Relmada Therapeutics, Inc. - Common Stock | 3.51 USD | +3.54% | +0.29% | -22.52% | +77.27% | 374.41 M USD | ||
| 3090 |  ARCT Arcturus Therapeutics Holdings Inc. - Common Stock | 12.61 USD | -8.22% | -14.22% | -13.75% | -33.56% | 358.41 M USD | ||
| 3099 |  OBIO Orchestra BioMed Holdings, Inc. - Ordinary Shares | 5.91 USD | -0.67% | -2.31% | -3.27% | +84.69% | 355.22 M USD | ||
| 3146 |  AGEN Agenus Inc. - Common Stock | 7.43 USD | -3.13% | -12.49% | +5.69% | +86.22% | 334.50 M USD |